IGM Biosciences Inc. (IGMS) Misses Q2 EPS by 3c

IGM Biosciences Inc. (NASDAQ: IGMS) reported Q2 EPS of ($1.43), $0.03 worse than the analyst estimate of ($1.40). Revenue for the quarter came in at $450 thousand versus the consensus estimate of $797 thousand.

For earnings history and earnings-related data on IGM Biosciences Inc. (IGMS) click here.

You May Also Be Interested In

• TJX stock drops as profit outlook falls short of analyst estimates
• Lowe's slashes full-year sales outlook amid DIY spending pressure
• Target (TGT) Tops Q2 EPS by $1.78, Beats on Revenue; Offers FY27 EPS Guidance